-
5101por Araki, Alejandra S., Vigoder, Felipe M., Bauzer, Luiz G. S. R., Ferreira, Gabriel E. M., Souza, Nataly A., Araújo, Izeneide B., Hamilton, James G. C., Brazil, Reginaldo P., Peixoto, Alexandre A.“…BACKGROUND: Lutzomyia longipalpis is the primary vector of American visceral leishmaniasis. There is strong evidence that L. longipalpis is a species complex, but until recently the existence of sibling species among Brazilian populations was considered a controversial issue. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5102“…Leishmaniasis is a major health problem in many parts of the world, caused by various species of Leishmania. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5103por Garg, Ravendra, Barat, Corinne, Ouellet, Michel, Lodge, Robert, Tremblay, Michel J.“…BACKGROUND: Visceral leishmaniasis has emerged as an important opportunistic disease among patients infected with HIV-1. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5104“…This phosphinate analogue remains the most potent enzyme inhibitor identified to date, and represents a good starting point for drug discovery for trypanosomiasis and leishmaniasis.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5105por Colomba, Claudia, Saporito, Laura, Vitale, Fabrizio, Reale, Stefano, Vitale, Giustina, Casuccio, Alessandra, Tolomeo, Manlio, Maranto, Daniela, Rubino, Raffaella, Di Carlo, Paola, Titone, Lucina“…BACKGROUND: Visceral leishmaniasis (VL) is a protozoan diseases caused in Europe by Leishmania (L.) infantum. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5106por Kumar, Pranav, Lodge, Robert, Trudel, Nathalie, Ouellet, Michel, Ouellette, Marc, Tremblay, Michel J.“…BACKGROUND: Visceral leishmaniasis has now emerged as an important opportunistic disease in patients coinfected with human immunodeficiency virus type-1 (HIV-1). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5107por Vanaerschot, Manu, Maes, Ilse, Ouakad, Meriem, Adaui, Vanessa, Maes, Louis, De Doncker, Simonne, Rijal, Suman, Chappuis, François, Dujardin, Jean-Claude, Decuypere, Saskia“…BACKGROUND: Leishmania donovani is an intracellular protozoan parasite that causes a lethal systemic disease, visceral leishmaniasis (VL), and is transmitted between mammalian hosts by phlebotomine sandflies. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5108“…DISCUSSION: We present three infectious vector-borne diseases—Chagas, leishmaniasis, and malaria—and discuss evidence that suggests that the use of artificial lighting results in behavioral changes among human populations and changes in the prevalence of vector species and in the modes of transmission. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5109por Gannavaram, Sreenivas, Sharma, Paresh, Duncan, Robert C., Salotra, Poonam, Nakhasi, Hira L.“…Thus, Ufm1 conjugation pathway in Leishmania could be explored as a potential drug target in the control of Leishmaniasis.…”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5110“…The analysis had textual and bibliometric facets, and focussed on chikungunya, dengue, visceral leishmaniasis, and onchocerciasis. RESULTS: There is substantial variation in the number of publications associated with each disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5111por Diaz-Albiter, Hector, Mitford, Roanna, Genta, Fernando A., Sant'Anna, Mauricio R. V., Dillon, Rod J.“…The phlebotomine sand fly Lutzomyia longipalpis is the most important vector of American visceral leishmaniasis (AVL), the disseminated and most serious form of the disease in Central and South America. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5112“…BACKGROUND: In areas endemic for visceral leishmaniasis (VL), a large number of infected individuals mount a protective cellular immune response and remain asymptomatic carriers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
5113“…BACKGROUND: Miltefosine, which is the first oral drug licensed for the treatment of leishmaniasis, was recently reported to be a promising lead compound for the synthesis of novel antischistosomal derivatives with potent activity in vivo against different developmental stages of Schistosoma mansoni. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5114por Coutinho-Abreu, Iliano V, Mukbel, Rami, Hanafi, Hanafi A, Fawaz, Emad Y, El-Hossary, Shabaan S, Wadsworth, Mariha, Stayback, Gwen, Pitts, Dilkushi A, Abo-Shehada, Mahmoud, Hoel, David F, Kamhawi, Shaden, Ramalho-Ortigão, Marcelo, McDowell, Mary Ann“…BACKGROUND: Sand fly saliva can drive the outcome of Leishmania infection in animal models, and salivary components have been postulated as vaccine candidates against leishmaniasis. In the sand fly Phlebotomus papatasi, natural sugar-sources modulate the activity of proteins involved in meal digestion, and possibly influence vectorial capacity. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5115por Hejazi, H, Tasbihi, M, Jaafari, Mr, Badiee, A, Pestechian, N, Javadi, A, Khamesipour, A“…BACKGROUND: Historically, leishmanization is the most effective protective measure against Cutaneous Leishmaniasis (CL), CL lesion induced by leishmanization sometimes takes a long time to heal. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5116por Mahmoudzadeh-Niknam, H, Abrishami, F, Doroudian, M, Moradi, M, Alimohammadian, MH, Parvizi, P, Hatam, GhR, Mohebali, M, Khalaj, V“…BACKGROUND: Leishmaniasis is endemic in Iran. Different species of Leishmania (L.) parasites are causative agents of this disease. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5117por Smandi, Sondos, Guerfali, Fatma Z, Farhat, Mohamed, Ben-Aissa, Khadija, Laouini, Dhafer, Guizani-Tabbane, Lamia, Dellagi, Koussay, Benkahla, Alia“…BACKGROUND: Leishmaniasis are widespread parasitic-diseases with an urgent need for more active and less toxic drugs and for effective vaccines. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5118“…Prevalence in humans remained lower than 5% for dengue, leishmaniasis and Japanese encephalitis, but substantially higher for diseases with longer duration of infection; malaria and the American and African trypanosomiasis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5119por Genois, Marie-Michelle, Mukherjee, Angana, Ubeda, Jean-Michel, Buisson, Rémi, Paquet, Eric, Roy, Gaétan, Plourde, Marie, Coulombe, Yan, Ouellette, Marc, Masson, Jean-Yves“…Collectively, our data show that LiBRCA2 and LiRAD51 promote HR at the genetic and biochemical level in L. infantum, the causative agent of visceral leishmaniasis.…”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5120por S, Zapata, L, Mejía, F, Le Pont, R, León, B, Pesson, C, Ravel, L, Bichaud, R, Charrel, C, Cruaud, G, Trueba, J, Depaquit“…BACKGROUND: Cutaneous leishmaniasis is endemic to the Pacific coast of Ecuador, and Nyssomyia trapidoi is considered to be its main vector. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto